ENTITY
CSL Ltd

CSL Ltd (CSL AU)

227
Analysis
Health Care • Australia
CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
bearish•MSCI ACWI Index
•27 Mar 2020 09:25

Global Equity Strategy: Initial Low Established

Several equity indexes and indicators we watch are telling us an initial primary low has been established for global equities (ACWI-US). At the...

Logo
634 Views
Share
•19 Oct 2019 10:51

Aussie Equities Model Portfolio Update (October): Sticking to the Knitting

Our model portfolio has added 200bp of Alpha since our last update and our stock selection remains broadly unchanged.  However, we make some key...

Logo
512 Views
Share
•30 Sep 2019 07:47

Developed Markets Opportunities

Continue to favor EAFE over EM. As long as the U.S. dollar remains elevated, we believe  developed international (EAFE) will remain in a leadership...

Logo
734 Views
Share
•20 Sep 2019 11:25

The Deadcat Bounce in Aussie Value

The Global rotation away from Defensive stocks to cyclical Growth and Value over the past few weeks has not been impressive enough to convince us...

Logo
846 Views
Share
•09 Sep 2019 08:22

Global Equity Strategy: Guarded Optimism

Global equities (MSCI ACWI) are decisively breaking above 1-month resistance on US-China trade war optimism, incrementally improving the technical...

Logo
528 Views
Share
x